Michael S. Cookson, MD, MMHC, presented “A Urologist’s Perspective on Germline Testing” for the Grand Rounds in Urology audience in October, 2019.
How to cite: Cookson, Michael S. “A Urologist’s Perspective on Germline Testing” October, 2019. Accessed Jan 2021. https://grandroundsinurology.com/a-urologists-perspective-on-germline-testing/
A Urologist’s Perspective on Germline Testing – Summary:
Michael S. Cookson, MD, MMHC, stresses that, in the current landscape of increased public awareness and commercial availability of germline testing, urologists must stay informed in order to utilize genetic information for the risk assessment, prevention, and prognosis of prostate cancer, as well as guide treatment selections. Dr. Cookson then reviews the existing guidelines regarding the role of germline testing in managing prostate cancer, including recommendations from the Society of Urologic Oncology, National Comprehensive Cancer Network, and the Philadelphia Prostate Cancer Consensus.
This educational activity is based on a series of lectures on genetic testing for prostate cancer from the 2019 Philadelphia Prostate Cancer Consensus Conference. Further activities from this conference include:
Germline Predisposition for Prostate Cancer Among African American and Other Minorities: What Do We Know?
Molecular Insights into the Germline for Prostate Cancer Initiation, Progression, and Aggressiveness
Prostate Cancer Screening & Genetic Testing: The NCCN Perspective
Integration of Germline Testing in Prostate Cancer Screening
Current Prostate Cancer Genetic Testing Capabilities and Considerations
Current NCCN Recommendations for Prostate Cancer Genetic Testing
The Expanding World of Germline Testing for Prostate Cancer: Genetic Counseling Perspective
The Expanding World of Germline Testing for Prostate Cancer: A Clinical Trials Perspective